HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xinping Cao Selected Research

Retreatment

1/2019Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xinping Cao Research Topics

Disease

16Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2024 - 02/2011
8Neoplasms (Cancer)
11/2023 - 02/2011
3Neoplasm Metastasis (Metastasis)
11/2021 - 01/2016
2Hematologic Neoplasms (Hematological Malignancy)
10/2023 - 01/2023
2Carcinoma (Carcinomatosis)
01/2021 - 01/2019
1Abdominal Pain (Pain, Abdominal)
05/2024
1Diarrhea
05/2024
1Hodgkin Disease (Hodgkin's Disease)
01/2024
1Bites and Stings (Sting)
11/2023
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2023
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2023
1Multiple Myeloma
01/2022
1Thrombocytopenia (Thrombopenia)
01/2021
1Neutropenia
01/2021
1Anemia
01/2021
1Nasopharyngeal Carcinoma
01/2019
1Enteritis
11/2014
1Inflammation (Inflammations)
11/2014
1Endometrial Neoplasms (Endometrial Cancer)
04/2013

Drug/Important Bio-Agent (IBA)

4Chimeric Antigen ReceptorsIBA
01/2024 - 01/2023
4Proteins (Proteins, Gene)FDA Link
10/2023 - 11/2014
2squamous cell carcinoma-related antigenIBA
11/2023 - 08/2023
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2011
2Pyruvate KinaseIBA
01/2019 - 01/2018
2IsoenzymesIBA
01/2019 - 01/2018
2CateninsIBA
01/2018 - 01/2016
2Docetaxel (Taxotere)FDA Link
04/2013 - 02/2011
1Superoxide DismutaseIBA
05/2024
1Antiviral Agents (Antivirals)IBA
11/2023
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2023
1UbiquitinIBA
11/2023
1InterferonsIBA
11/2023
1Phosphotransferases (Kinase)IBA
11/2023
1Oncogene Proteins (Oncogene Protein)IBA
11/2023
1AntigensIBA
08/2023
1tislelizumabIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2022
1nedaplatinIBA
01/2021
1apatinibIBA
12/2020
1Tyrosine Kinase InhibitorsIBA
12/2020
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2020
1camrelizumabIBA
12/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2019
1EnzymesIBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1MicroRNAs (MicroRNA)IBA
04/2015
1Carboplatin (JM8)FDA LinkGeneric
04/2013

Therapy/Procedure

9Radiotherapy
05/2024 - 04/2013
3Chemoradiotherapy
05/2024 - 10/2019
3Therapeutics
10/2023 - 12/2020
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2019 - 12/2017
2Hysterectomy
04/2021 - 02/2011
2Adjuvant Chemotherapy
10/2019 - 04/2013
2Brachytherapy
01/2019 - 01/2019
1Enema (Enemas)
05/2024
1Re-Irradiation
11/2023
1Salvage Therapy
11/2023
1Immunotherapy
01/2023
1Operative Surgical Procedures
11/2021
1Retreatment
01/2019
1Conformal Radiotherapy
09/2018
1Drug Therapy (Chemotherapy)
04/2013
1Combination Drug Therapy (Combination Chemotherapy)
04/2013
1Neoadjuvant Therapy
02/2011
1Lymph Node Excision (Lymph Node Dissection)
02/2011